Search





Search





Markets
/
Stocks
/
nasdaq-dgx
/

Quest Diagnostics Inc

DGX

Add to Watchlist

188.130USD

-2.050-1.08%

Market hours （ET）Quotes delayed by 15 min

20.88BMarket Cap

20.43P/E TTM



Quest Diagnostics Inc

188.130

-2.050-1.08%

Overview Financials Discussions Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Quest Diagnostics Inc

Currency: USD Updated: 2026-05-12

Key Insights

Quest Diagnostics Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 221.70.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quest Diagnostics Inc's Score

Industry at a Glance

Industry Ranking

17 / 75

Overall Ranking

95 / 4490

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Quest Diagnostics Inc Highlights

StrengthsRisks

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 19.27% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 11.04B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 38.22%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 38.22%.

Fairly Valued

The company’s latest PE is 20.65, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 110.61M shares, decreasing 2.78% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 1.70K shares of this stock.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

221.702

Target Price

+18.31%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-12

The current financial score of Quest Diagnostics Inc is 8.10, ranking 20 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 2.90B, representing a year-over-year increase of 9.16%, while its net profit experienced a year-over-year increase of 14.61%.

Score

Industry at a Glance

Previous score

8.10

Change



Financials

5.81

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.72

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.15

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.92

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

8.88

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Quest Diagnostics Inc's Company Valuation

Currency: USD Updated: 2026-05-12

The current valuation score of Quest Diagnostics Inc is 6.63, ranking 48 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 20.65, which is 15.29% below the recent high of 23.81 and 21.56% above the recent low of 16.20.

Score

Industry at a Glance

Previous score

6.63

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 17/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-12

The current earnings forecast score of Quest Diagnostics Inc is 7.50, ranking 38 out of 75 in the Healthcare Providers & Services industry. The average price target is 198.00, with a high of 215.00 and a low of 169.18.

Score

Industry at a Glance

Previous score

7.50

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

221.702

Target Price

+18.31%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Quest Diagnostics Inc

DGX

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-12

The current price momentum score of Quest Diagnostics Inc is 6.93, ranking 53 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 204.57 and the support level at 181.01, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.86

Change

0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.936

Sell

RSI(14)

43.968

Neutral

STOCH(KDJ)(9,3,3)

32.435

Buy

ATR(14)

4.600

Low Volatility

CCI(14)

-47.141

Neutral

Williams %R

79.671

Sell

TRIX(12,20)

-0.152

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

189.470

Sell

MA10

190.588

Sell

MA20

193.831

Sell

MA50

196.481

Sell

MA100

192.542

Sell

MA200

187.108

Buy

Institutional Confidence

Currency: USD Updated: 2026-05-12

The current institutional shareholding score of Quest Diagnostics Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 99.92%, representing a quarter-over-quarter increase of 0.03%. The largest institutional shareholder is PRFDX, holding a total of 6.13M shares, representing 5.54% of shares outstanding, with 6.23% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

6.17M

+0.73%

T. Rowe Price Associates, Inc.

Star Investors

6.13M

-10.35%

State Street Investment Management (US)

5.38M

+3.04%

Boston Partners

3.91M

-3.06%

JP Morgan Asset Management

3.74M

-1.03%

Geode Capital Management, L.L.C.

3.03M

-0.27%

Victory Capital Management Inc.

2.13M

-9.28%

Dimensional Fund Advisors, L.P.

1.93M

+1.26%

Risk Assessment

Currency: USD Updated: 2026-05-12

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Quest Diagnostics Inc is 9.69, ranking 1 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.60. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Quest Diagnostics Inc’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.